I am really excited about the opportunity to take a fresh look at a broader range of questions in pharmaceutical mergers than our traditional approach has taken.
Editor's note · Context
Slaughter expresses enthusiasm for examining pharmaceutical mergers more comprehensively.
Share
More from Louise Slaughter
Passengers deserve only the best-trained pilots, and I commend Secretary LaHood and Administrator Babbitt for recently ordering the FAA inspectors to ensure that regional carrier training programs are complying with the Federal regulations.
Yes, so I think for a long time there has been a general sense in the antitrust world that vertical mergers are rarely bad, and in fact, may be mostly good.
These are victims in the strongest sense of the word, the children who have been preyed upon by those who would take advantage of the situation.
The FDA needs clear statutory direction to take aggressive action against this resistance.





